Does TREPROSTINIL Cause Pericardial effusion? 584 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 584 reports of Pericardial effusion have been filed in association with TREPROSTINIL (TYVASO). This represents 0.6% of all adverse event reports for TREPROSTINIL.
584
Reports of Pericardial effusion with TREPROSTINIL
0.6%
of all TREPROSTINIL reports
86
Deaths
502
Hospitalizations
How Dangerous Is Pericardial effusion From TREPROSTINIL?
Of the 584 reports, 86 (14.7%) resulted in death, 502 (86.0%) required hospitalization, and 35 (6.0%) were considered life-threatening.
Is Pericardial effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 584 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Pericardial effusion?
IBRUTINIB (467)
CYCLOPHOSPHAMIDE (458)
NIVOLUMAB (454)
METHOTREXATE (412)
MACITENTAN (407)
DASATINIB (388)
ADALIMUMAB (374)
AMBRISENTAN (371)
PEMBROLIZUMAB (362)
PREDNISONE (339)
Which TREPROSTINIL Alternatives Have Lower Pericardial effusion Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE